Skip to content

Symplicity Spyral Multi-Electrode Renal Denervation Catheter

by Medtronic, Inc. PMA

Active United States

PMA P220026

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP220026 Date17 Nov 2023ApprovedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

PMA

Trade Name
Symplicity Spyral™ Renal Denervation System
Generic Name
Ablation catheter, renal denervation
PMA Number
FDA Product Code
QYI
Device Class
Class III
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Symplicity Spyral Multi-Electrode Renal Denervation Catheter is an ablation catheter designed for renal denervation. It delivers radiofrequency energy to the renal arteries to reduce blood pressure in patients with uncontrolled hypertension despite lifestyle modifications and antihypertensive medications.

This catheter is supplied as a single-use device and is intended for use in interventional radiology or cardiology settings. It is regulated under FDA Premarket Approval (PMA P220026) and classified as a Class III device. Sterility and proper handling per manufacturer instructions are required before use, and it must be stored according to the provided guidelines.

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, and how does it work?

    The Symplicity Spyral Multi-Electrode Renal Denervation Catheter is designed to reduce blood pressure in patients with uncontrolled hypertension who have not responded adequately to lifestyle changes and medications. It works by delivering radiofrequency energy to the renal arteries, which helps to disrupt nerve signals that contribute to elevated blood pressure.

  • Is this device intended for single-use or repeated use, and what are the storage requirements?

    The Symplicity Spyral Multi-Electrode Renal Denervation Catheter is a single-use device, meaning it is not meant to be reused after one procedure. Proper storage must follow the manufacturer’s guidelines to maintain sterility and functionality, as sterility is required before use.

  • What types of medical specialties or settings are this catheter intended for, and how is it supplied?

    This catheter is intended for use in interventional radiology or cardiology settings, where specialized procedures like renal denervation are performed. It is supplied as a complete single-use system, ready for immediate use in these controlled clinical environments.

  • What regulatory approval does the Symplicity Spyral Multi-Electrode Renal Denervation Catheter hold, and how does that affect its use?

    The device holds FDA Premarket Approval (PMA P220026), confirming it meets stringent regulatory standards as a Class III medical device. This approval ensures it has been thoroughly evaluated for safety and effectiveness as an adjunctive treatment for hypertension in eligible patients, guiding its authorized use in clinical practice.